Aging and drug discovery

Research output: Contribution to journalJournal articleResearchpeer-review


  • Alexander M. Aliper
  • Polina Mamoshina
  • Joseph A. Baur
  • Judith Campisi
  • Collin Y. Ewald
  • Anastasia Georgievskaya
  • Vadim N. Gladyshev
  • Olga Kovalchuk
  • Dudley W. Lamming
  • Martijn S. Luijsterburg
  • Alejandro Martín-Montalvo
  • Stuart Maudsley
  • Alexey Moskalev
  • S. Jay Olshansky
  • Ivan V. Ozerov
  • Alexander Pickett
  • Michael Ristow
  • Alex Zhavoronkov

Multiple interventions in the aging process have been discovered to extend the healthspan of model organisms. Both industry and academia are therefore exploring possible transformative molecules that target aging and age-associated diseases. In this overview, we summarize the presented talks and discussion points of the 5th Annual Aging and Drug Discovery Forum 2018 in Basel, Switzerland. Here academia and industry came together, to discuss the latest progress and issues in aging research. The meeting covered talks about the mechanistic cause of aging, how longevity signatures may be highly conserved, emerging biomarkers of aging, possible interventions in the aging process and the use of artificial intelligence for aging research and drug discovery. Importantly, a consensus is emerging both in industry and academia, that molecules able to intervene in the aging process may contain the potential to transform both societies and healthcare.

Original languageEnglish
Issue number11
Pages (from-to)3079-3088
Number of pages10
Publication statusPublished - 2018

    Research areas

  • Aging, Drug discovery

Number of downloads are based on statistics from Google Scholar and

No data available

ID: 212126630